The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Bruce W. Bode

Atlanta Diabetes Associates

77 Collier Rd

Ste 2080

Atlanta

USA

[email]@aol.com

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Atlanta Diabetes Associates, 77 Collier Rd, Ste 2080, Atlanta, USA. 2000 - 2011
  • Diabetes Resource Center, Piedmont Hospital in Atlanta, USA. 2002

References

  1. Liraglutide: a review of the first once-daily GLP-1 receptor agonist. Bode, B. Am. J. Manag. Care (2011) [Pubmed]
  2. Comparison of pharmacokinetic properties, physicochemical stability, and pump compatibility of 3 rapid-acting insulin analogues-aspart, lispro, and glulisine. Bode, B.W. Endocr. Pract (2011) [Pubmed]
  3. Insulin pump use in type 2 diabetes. Bode, B.W. Diabetes Technol. Ther. (2010) [Pubmed]
  4. Patient-reported outcomes following treatment with the human GLP-1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetes. Bode, B.W., Testa, M.A., Magwire, M., Hale, P.M., Hammer, M., Blonde, L., Garber, A. Diabetes. Obes. Metab (2010) [Pubmed]
  5. Defining the importance of daily glycemic control and implications for type 2 diabetes management. Bode, B.W. Postgrad. Med (2009) [Pubmed]
  6. Demonstrations and discussions of continuous glucose monitors. Bode, B.W. Diabetes Technol. Ther. (2005) [Pubmed]
  7. Patient perception and use of an insulin injector/glucose monitor combined device. Bode, B., Shelmet, J., Gooch, B., Hassman, D.R., Liang, J., Smedegaard, J.K., Skovlund, S., Berg, B., Lyness, W., Schneider, S.H. Diabetes. Educ (2004) [Pubmed]
  8. Diabetes management in the new millennium using insulin pump therapy. Bode, B.W., Sabbah, H.T., Gross, T.M., Fredrickson, L.P., Davidson, P.C. Diabetes Metab. Res. Rev. (2002) [Pubmed]
  9. Insulin pump therapy in the 21st century. Strategies for successful use in adults, adolescents, and children with diabetes. Bode, B.W., Tamborlane, W.V., Davidson, P.C. Postgrad. Med (2002) [Pubmed]
  10. Intensive insulin therapy and insulin pumps. Bode, B.W. Postgrad. Med (2002) [Pubmed]
  11. Efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes. Bode, B.W., Strange, P. Diabetes. Care (2001) [Pubmed]
  12. What's ahead in glucose monitoring? New techniques hold promise for improved ease and accuracy. Bode, B.W., Sabbah, H., Davidson, P.C. Postgrad. Med (2001) [Pubmed]
  13. Clinical utility of the continuous glucose monitoring system. Bode, B.W. Diabetes Technol. Ther. (2000) [Pubmed]
 
WikiGenes - Universities